newsfilter
← Latest News
GlobeNewswire·

Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various